Wolfram Klapper
Overview
Explore the profile of Wolfram Klapper including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
388
Citations
11776
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Glaser S, Fischer A, Martinez-Manjon J, Lopez C, Kretzmer H, Burkhardt B, et al.
Leukemia
. 2025 Mar;
PMID: 40065077
No abstract available.
2.
Kurz K, Steinlein S, Kreuz M, Ziepert M, Staiger A, Barth T, et al.
Hemasphere
. 2025 Mar;
9(3):e70093.
PMID: 40060117
Diffuse large B-cell lymphoma (DLBCL) is the most common non-Hodgkin lymphoma. Despite a high cure rate, too many patients show refractory (ref) or relapsed (rel) disease. This study examines the...
3.
Di Stefano G, Fischer A, Chteinberg E, Bens S, Wagener R, Abramov D, et al.
Genes Chromosomes Cancer
. 2025 Jan;
64(1):e70021.
PMID: 39846133
Mature aggressive B-cell lymphomas, such as Burkitt lymphoma (BL) and Diffuse large B-cell lymphoma (DLBCL), show variations in microRNA (miRNA) expression. The entity of High-grade B-cell lymphoma with 11q aberration...
4.
Whole-Exome Sequencing, Mutational Signature Analysis, and Outcome in Multiple Myeloma-A Pilot Study
Oelschlager L, Kunstner A, Frey F, Leitner T, Leypoldt L, Reimer N, et al.
Int J Mol Sci
. 2025 Jan;
25(24.
PMID: 39769182
The complex and heterogeneous genomic landscape of multiple myeloma (MM) and many of its clinical and prognostic implications remains to be understood. In other cancers, such as breast cancer, using...
5.
Mendeville M, Janssen J, Los-de Vries G, van Dijk E, Richter J, Nijland M, et al.
Nat Commun
. 2025 Jan;
16(1):109.
PMID: 39747123
Next Generation Sequencing-based subtyping and interim- and end of treatment positron emission tomography (i/eot-PET) monitoring have high potential for upfront and on-treatment risk assessment of diffuse large B-cell lymphoma patients....
6.
Daw S, Claviez A, Kurch L, Stoevesandt D, Attarbaschi A, Balwierz W, et al.
JAMA Oncol
. 2025 Jan;
PMID: 39745682
Importance: The current standard-of-care salvage therapy in relapsed/refractory classic Hodgkin lymphoma (cHL) includes consolidation high-dose chemotherapy (HDCT)/autologous stem cell transplant (aSCT). Objective: To investigate whether presalvage risk factors and fludeoxyglucose-18...
7.
Seifert N, Reinke S, Grund J, Muller-Meinhard B, Richter J, Heilmann T, et al.
Leukemia
. 2024 Dec;
39(3):684-693.
PMID: 39690183
The Tumor Microenvironment (TME) in classical Hodgkin Lymphoma (HL) contains abundant immune cells and only few neoplastic Hodgkin and Reed-Sternberg cells (HRSC). We analyzed the T-cell receptor (TCR) repertoire to...
8.
Fahnrich A, Gasimova Z, Maluje Y, Ott F, Sievert H, Fliedner S, et al.
Front Oncol
. 2024 Oct;
14:1445427.
PMID: 39391235
Tenosynovial giant cell tumor (TGCT) is a rare type of tumor that originates from the synovium of joints and tendon sheaths. It is characterized by recurring genetic abnormalities, often involving...
9.
Spada F, Rosenwald A, Klapper W, Feller A, Fend F, Ott G, et al.
Am J Clin Pathol
. 2024 Oct;
163(2):277-289.
PMID: 39373181
Objectives: Primary nodal marginal B-cell lymphoma (NMZL) is rare and histologically very variable. Its large-cell presentation is difficult to distinguish from nodal diffuse large B-cell lymphoma (nDLBCL) due to the...
10.
Fischer A, Albert T, Moreno N, Interlandi M, Mormann J, Glaser S, et al.
Nat Commun
. 2024 Oct;
15(1):8571.
PMID: 39362842
Peripheral T-cell lymphoma, not otherwise specified (PTCL-NOS) is a heterogeneous group of malignancies with poor outcome. Here, we identify a subgroup, PTCL-NOS, which is characterized by the lack of the...